Yes, Cytotec (misoprostol) is FDA approved, but only for one specific purpose: reducing the risk of stomach ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen and aspirin. It was approved by the FDA and is manufactured by Pfizer. What makes Cytotec unusual is that its most well-known uses today, including medication abortion and labor induction, are technically off-label, meaning the FDA never formally approved the drug for those purposes.
What Cytotec Is Approved For
The FDA approved Cytotec specifically for preventing gastric ulcers in people who take NSAIDs regularly and face a high risk of complications. That includes older adults, people with other serious health conditions, and anyone with a history of stomach ulcers. The approved dose for this purpose is 200 micrograms taken two to four times daily.
Misoprostol works by mimicking a natural substance in the body (a prostaglandin) that protects the stomach lining. NSAIDs suppress that protective mechanism, which is why long-term NSAID users are prone to ulcers. Cytotec essentially replaces what the painkillers strip away.
Off-Label Use in Abortion and Labor
The same property that makes misoprostol useful for the stomach, its ability to trigger prostaglandin activity, also causes the uterus to contract. This is why the drug became widely used in reproductive medicine, despite never being approved for it.
In medication abortion, misoprostol is part of the FDA-approved regimen for mifepristone (a different drug sold under a separate approval). That protocol calls for 200 mg of mifepristone taken by mouth on day one, followed 24 to 48 hours later by 800 mcg of misoprostol placed in the cheek pouch. So while misoprostol plays a central role in medication abortion, it’s the mifepristone product that carries the FDA approval for pregnancy termination, not Cytotec itself.
For labor induction, misoprostol is also used off-label to soften the cervix and stimulate contractions. A large body of published research, including two major network meta-analyses, supports its safety and effectiveness for this purpose. Studies have found that vaginal doses of 50 micrograms give the highest probability of achieving vaginal delivery within 24 hours. Many hospitals use it routinely, but again, this is not an FDA-approved indication for the Cytotec brand.
The Black Box Warning
Cytotec carries the FDA’s most serious type of warning, a boxed (or “black box”) warning, specifically about use during pregnancy. The label states in bold terms that giving misoprostol to pregnant women can cause birth defects, abortion, premature birth, or uterine rupture. The risk of a torn uterus increases later in pregnancy and in women who have had prior uterine surgery, including a previous cesarean delivery.
This warning exists because the drug was approved to prevent stomach ulcers, not to be used during pregnancy. The FDA wanted to make clear that pregnant women should not take Cytotec for ulcer prevention, and that patients need to be informed about the drug’s ability to cause abortion. The label explicitly states that patients “must be advised of the abortifacient property and warned not to give the drug to others.”
A torn uterus is the most dangerous potential complication. It can lead to severe bleeding, emergency removal of the uterus, and in rare cases, death of the mother or baby. These risks are highest in women who have had multiple births or previous uterine surgeries.
Why the Distinction Matters
Off-label prescribing is legal and common across medicine. Doctors regularly prescribe medications for uses the FDA hasn’t formally reviewed, as long as there’s reasonable evidence supporting the practice. Misoprostol’s reproductive uses have decades of clinical evidence behind them and are endorsed by major medical organizations. The fact that Cytotec isn’t FDA approved for these purposes doesn’t mean the uses are unproven or illegitimate.
However, the distinction does have practical implications. Because Cytotec’s approved indication is ulcer prevention, its labeling, dosing instructions, and safety warnings are all written with that use in mind. When the drug is prescribed for labor induction or abortion, the doses, routes of administration, and risk profiles differ significantly from what appears on the official label. Clinicians rely on separate clinical guidelines rather than the Cytotec package insert when using it for reproductive purposes.
The regulatory landscape also means that state-level restrictions on abortion medications sometimes treat misoprostol differently depending on whether it’s being prescribed for its FDA-approved use or for pregnancy-related purposes. The same pill can face different legal requirements depending on the reason it’s being prescribed.

